Up next

Autoplay

Dr. Saad on the Safety Profile of Apalutamide in M0CRPC

3 Views • 08/29/25
Share
Side Effects
Side Effects
Subscribers
0

Fred Saad, MD, FRCS, discusses the safety profile of apalutamide in nonmetastatic castration-resistant prostate cancer.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Show more
0 Comments sort Sort By

Up next

Autoplay